TWST Relative Valuation
TWST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TWST is overvalued; if below, it's undervalued.
Historical Valuation
Twist Bioscience Corp (TWST) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -17.72. The fair price of Twist Bioscience Corp (TWST) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：32.81
Fair
-22.06
PE
1Y
3Y
5Y
Trailing
Forward
-40.10
EV/EBITDA
Twist Bioscience Corp. (TWST) has a current EV/EBITDA of -40.10. The 5-year average EV/EBITDA is -18.39. The thresholds are as follows: Strongly Undervalued below -45.60, Undervalued between -45.60 and -32.00, Fairly Valued between -4.78 and -32.00, Overvalued between -4.78 and 8.83, and Strongly Overvalued above 8.83. The current Forward EV/EBITDA of -40.10 falls within the Undervalued range.
-18.74
EV/EBIT
Twist Bioscience Corp. (TWST) has a current EV/EBIT of -18.74. The 5-year average EV/EBIT is -15.45. The thresholds are as follows: Strongly Undervalued below -39.60, Undervalued between -39.60 and -27.53, Fairly Valued between -3.38 and -27.53, Overvalued between -3.38 and 8.69, and Strongly Overvalued above 8.69. The current Forward EV/EBIT of -18.74 falls within the Historic Trend Line -Fairly Valued range.
4.42
PS
Twist Bioscience Corp. (TWST) has a current PS of 4.42. The 5-year average PS is 13.91. The thresholds are as follows: Strongly Undervalued below -16.87, Undervalued between -16.87 and -1.48, Fairly Valued between 29.29 and -1.48, Overvalued between 29.29 and 44.68, and Strongly Overvalued above 44.68. The current Forward PS of 4.42 falls within the Historic Trend Line -Fairly Valued range.
233.58
P/OCF
Twist Bioscience Corp. (TWST) has a current P/OCF of 233.58. The 5-year average P/OCF is 127.69. The thresholds are as follows: Strongly Undervalued below -1404.75, Undervalued between -1404.75 and -638.53, Fairly Valued between 893.91 and -638.53, Overvalued between 893.91 and 1660.12, and Strongly Overvalued above 1660.12. The current Forward P/OCF of 233.58 falls within the Historic Trend Line -Fairly Valued range.
112.12
P/FCF
Twist Bioscience Corp. (TWST) has a current P/FCF of 112.12. The 5-year average P/FCF is -11.67. The thresholds are as follows: Strongly Undervalued below -110.88, Undervalued between -110.88 and -61.28, Fairly Valued between 37.93 and -61.28, Overvalued between 37.93 and 87.54, and Strongly Overvalued above 87.54. The current Forward P/FCF of 112.12 falls within the Strongly Overvalued range.
Twist Bioscience Corp (TWST) has a current Price-to-Book (P/B) ratio of 4.21. Compared to its 3-year average P/B ratio of 3.62 , the current P/B ratio is approximately 16.09% higher. Relative to its 5-year average P/B ratio of 4.96, the current P/B ratio is about -15.26% higher. Twist Bioscience Corp (TWST) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -8.78%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -7.59% , the current FCF yield is about -100.00% lower.
4.21
P/B
Median3y
3.62
Median5y
4.96
-3.97
FCF Yield
Median3y
-8.78
Median5y
-7.59
Competitors Valuation Multiple
The average P/S ratio for TWST's competitors is 0.00, providing a benchmark for relative valuation. Twist Bioscience Corp Corp (TWST) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 16.88%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TWST decreased by 29.40% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 84.71M to 99.01M.
The secondary factor is the P/E Change, contributed -13.28%to the performance.
Overall, the performance of TWST in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Twist Bioscience Corp (TWST) currently overvalued or undervalued?
What is Twist Bioscience Corp (TWST) fair value?
How does TWST's valuation metrics compare to the industry average?
What is the current P/B ratio for Twist Bioscience Corp (TWST) as of Dec 05 2025?
What is the current FCF Yield for Twist Bioscience Corp (TWST) as of Dec 05 2025?
What is the current Forward P/E ratio for Twist Bioscience Corp (TWST) as of Dec 05 2025?